22nd Century Limited, LLC ("22nd Century Ltd"), our wholly-owned subsidiary, was founded in 1998 and is a plant biotechnology company focused on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. We exclusively control 114 issued patents and an additional 38 patent applications. Goodrich Tobacco Company and Hercules Pharmaceuticals are wholly-owned subsidiaries of 22nd Century Group. Goodrich Tobacco is focused on commercial tobacco products and potentially reduced-risk or modified risk tobacco products. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development. Stand 19.10.2016
WKN: A1W2NQ
ISIN: US90137F1030
Kürzel: XXII (OTC) in

handelbar:
JA
Gründungsjahr: 1998 Haupthandelsplatz
Vollzogene Namenswechsel Touchstone Mining Ltd. bis 12/2010 Land
Angestellte: 9